Programme

Europe faces rising demand for healthcare services at a time when public spending is under pressure coupled with persistent funding challenges and pricing pressures. In order to respond to these challenges the medtech sector needs to look at revising their business models and bringing innovation to the forefront of their strategies. This session will explore the current economic healthcare trends and the role of medtech in this sphere. Are there any new approaches to innovation? Where will growth come from? How can the medtech industry rise to this challenge? 

In the medical technology world mergers and acquisitions are very common but the question is whether or not they will continue to play a prominent role within such an uncertain environment. What are companies looking for when evaluating a potential acquisition or strategic alliance partnership? What are the obstacles for start up companies? Are there due diligence procedures that need to be considered? 

The economic crisis has had an impact on healthcare budgets so it is imperative for healthcare authorities to use their budgets wisely without jeopardising patient care. Is there a place for medical innovation to improve patient care? Will healthcare authorities see effectiveness not only at a clinical level but also at a financial level? What does this mean for medical device innovators? This session will outline best practice case studies and analyse which studies can be performed to show economic effectiveness.  

 

Concerns over VCs cutting back on investments is growing so who better to address this than the investors themselves. Panellists will discuss the current investment environment for medtech companies and what they should consider as they search for funding. What do they perceive the risks to be in this current climate? How can they be persuaded to invest earlier?